Journal article
Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007–2008 to 2023–2024
- Abstract:
- Aims: This study evaluated trends in glycaemic control in adults with Type 1 diabetes in England from 2007–2008 to 2023–2024, stratified by age, sex, ethnicity and socioeconomic deprivation. Materials and Methods: Adults aged ≥ 20 years from the National Diabetes Audit were analysed. Trends in mean HbA1c were assessed using linear mixed‐effects models. Logistic regression examined associations between sociodemographic factors and having an HbA1c ≤ 58 mmol/mol (≤ 7.5%); odds ratios were converted to relative risks. Results: In 2007–2008, 32.6% of 133 035 adults had an HbA1c ≤ 58 mmol/mol, increasing to 39.1% of 226 005 adults in 2023–2024. Mean HbA1c declined from 68.8 (95% CI: 68.6–69.0) to 66.2 mmol/mol (95% CI: 66.1–66.3). By age, the largest improvement occurred in those aged 20–24 years, from 76.7 to 70.1 mmol/mol (p < 0.001), while adults > 64 years saw a non‐significant increase from 63.7 to 63.8 mmol/mol (p = 0.203). Women consistently had higher mean HbA1c than men (2023–2024: 66.1 vs. 65.8 mmol/mol), declining from 69.4 to 66.1 mmol/mol in women and from 68.4 to 65.8 mmol/mol in men (both p < 0.001) and a lower adjusted probability of threshold attainment (38.4% [95% CI: 38.0–39.4] vs. 38.7% [95% CI: 38.2–39.3]). Marked ethnic inequalities persisted in 2023–2024: mean HbA1c was highest in Black (72.1 mmol/mol, 95% CI: 71.5–72.7) and Asian adults (69.8 mmol/mol, 95% CI: 69.4–70.2) compared with White adults (65.3 mmol/mol, 95% CI: 65.1–65.5). Socioeconomic gradients remained substantial, with threshold attainment at 46.4% (95% CI: 45.6–47.2) in the least deprived versus 32.3% (95% CI: 31.4–33.9) in the most deprived group. Conclusions: Although HbA1c improved overall, inequalities by age and deprivation widened, highlighting the need for equitable targeted care.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.1MB, Terms of use)
-
- Publisher copy:
- 10.1111/dom.70929
Authors
+ National Institute for Health and Care Research
More from this funder
- Funder identifier:
- 10.13039/501100000272
- Publisher:
- Wiley
- Journal:
- Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics More from this journal
- Article number:
- dom.70929
- Publication date:
- 2026-06-01
- Acceptance date:
- 2026-04-29
- DOI:
- EISSN:
-
1463-1326
- ISSN:
-
1462-8902
- Language:
-
English
- Keywords:
- Source identifiers:
-
4104641
- Deposit date:
-
2026-06-02
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record